Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins.

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

U.S. investors might not be as familiar with Roche, but the company's presence on the world stage is undeniable. By market capitalization, Roche is the fifth-largest pharmaceutical stock in the ...